Table 2.
The role of itaconate and derivatives in cancer
| Disease | Model | Agents | Mechanisms | Role | Reference |
|---|---|---|---|---|---|
| Colorectal cancer | DSS-induce mice model | DI | Inflammatory cytokine | Antitumor effect | Wang et al. |
| Peritoneal tumors | Peritoneal tumors-bearing mice | IRG1 deletion | OXPHOS, ROS, MAPK | Prompt tumor growth | Weiss et al. |
| Glioma | Xenograft transplantation model | IRG1 knockdown | Cell cycle regulatory proteins | Prompt tumor growth | Pan et al. |
| Retinoblastoma | Xenograft mouse models | 4-OI | Ferroptosis | Antitumor effect | Liu et al. |
| Thymic carcinoma | Cell line Ty82 | DI | LDHA-mTOR axis | Antitumor effect | Hayashi et al. |
| Hepatocellular carcinoma | Diethylnitrosamine-induced HCC | DI | Mitochondrial apoptosis | Antitumor effect | Gautam et al. |
| Breast cancer | Allografted tumors | IRG1 deletion | CD8+ T cells | Prompt tumor growth | Zhao et al. |